Back

touchIME, Partners for Advancing Clinical Education

  • Cardiomyopathy, Hypertrophic

Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies

In this activity, two experts provide insights on contemporary care for obstructive and nonobstructive HCM. They highlight the unmet needs of patients with HCM and discuss the evidence base for cardiac myosin inhibitors and other emerging therapeutic classes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 1.75 creditsPharmacyUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.75 credits
  • Commercial Support
  • Released
    Oct 20, 2025
  • Last day to claim credit
    Oct 21, 2026 10 days left